These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28596184)

  • 1. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Kremer JM; Weinblatt ME
    Ann Rheum Dis; 2018 Jan; 77(1):e4. PubMed ID: 28596184
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis by Kremer and Weinblatt.
    Humphreys JH; Costello R; Verstappen SM; Dixon WG
    Ann Rheum Dis; 2018 Jan; 77(1):e5. PubMed ID: 28596185
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Humphreys JH; Warner A; Costello R; Lunt M; Verstappen SMM; Dixon WG
    Ann Rheum Dis; 2017 Sep; 76(9):1509-1514. PubMed ID: 28341765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Methotrexate and NSAIDs in rheumatoid arthritis-Confirmation of a known NSAIDs adverse effect rather than a dangerous combination".
    Al-Khalili O; Mikuls TR; O'Dell JR; England BR
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1429. PubMed ID: 30421828
    [No Abstract]   [Full Text] [Related]  

  • 5. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
    Rajakulendran S; Gadsby K; Deighton C
    Musculoskeletal Care; 2008 Dec; 6(4):233-45. PubMed ID: 18702106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (Bi)Weekly folic acid supplementation might be inferior to a daily folic acid dosing schedule in the prevention of methotrexate-related toxicity in patients with rheumatoid arthritis.
    van den Bemt BJ; den Broeder AA; Van der Burgt M; Fransen J; van Ede AE; van den Hoogen FH
    Clin Exp Rheumatol; 2015; 33(5):767-8. PubMed ID: 26316162
    [No Abstract]   [Full Text] [Related]  

  • 7. The development of a questionnaire to evaluate rheumatoid arthritis patient's knowledge about methotrexate.
    Fayet F; Savel C; Rodere M; Pereira B; Abdi D; Mathieu S; Tournadre A; Soubrier M; Dubost JJ
    J Clin Nurs; 2016 Mar; 25(5-6):682-9. PubMed ID: 26526669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Effects of Low-Dose Methotrexate.
    Robey RB; Block CA
    Ann Intern Med; 2020 Jul; 173(2):166-167. PubMed ID: 32687752
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse Effects of Low-Dose Methotrexate.
    Solomon DH; Sparks JA
    Ann Intern Med; 2020 Jul; 173(2):167. PubMed ID: 32687751
    [No Abstract]   [Full Text] [Related]  

  • 10. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study.
    Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S
    Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
    Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric adverse drug reactions associated with low dose methotrexate in rheumatoid arthritis patients.
    Van Lint JA; Bakker T; Ten Klooster PM; van Puijenbroek EP; Vonkeman HE; Jessurun NT
    Expert Opin Drug Saf; 2022 Mar; 21(3):417-423. PubMed ID: 34739327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of comedication with folic or folinic acid on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a randomized, double blind, placebo controlled study of 48 weeks].
    Jansen TL; Spoorenberg A; Houtman PM; van Roon EN
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2168; author reply 2168. PubMed ID: 12474559
    [No Abstract]   [Full Text] [Related]  

  • 15. Side effects and management of side effects of methotrexate in rheumatoid arthritis.
    Albrecht K; Müller-Ladner U
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S95-101. PubMed ID: 21044440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alcohol and patients with gout].
    Løvschall S
    Ugeskr Laeger; 2002 Aug; 164(35):4084; author reply 4084-5. PubMed ID: 12229314
    [No Abstract]   [Full Text] [Related]  

  • 17. The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.
    Li X; Hu M; Li W; Gu L; Chen M; Ding H; Vanarsa K; Du Y
    Int Immunopharmacol; 2016 Sep; 38():8-15. PubMed ID: 27233001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of sarilumab for the treatment of rheumatoid arthritis.
    Lee EB
    Immunotherapy; 2018 Jan; 10(1):57-65. PubMed ID: 29043871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary investigation of cognitive function in rheumatoid arthritis patients on long-term methotrexate treatment.
    Meade T; Cumming S; Hallab L; Spencer D; Howe G; Manolios N
    J Health Psychol; 2013 Oct; 18(10):1353-9. PubMed ID: 23188915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to effectively use methotrexate in rheumatoid arthritis?].
    Hernandez-Baldizon S
    Reumatol Clin; 2012; 8(1):42-5. PubMed ID: 22089073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.